Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
" Vela it broke your 1470p zone today !!! "
----------------------
Yep, I'm well pleased with that F/Jack.
I have a particular strategy for this stock and after messing up my entry I'm pleased I corrected myself, even though leaving everything as was, I'd have some profit to show.
(With my rare metals and miners stocks, yes I bottom-feed - but not here).
I've always maintained this is in a long term uptrend despite the ferocious retraces and pull backs - using monthly prices to manage this stock with little management.
I have 2 concerns:
If this closes the month below 1470 I'm forced by my self imposed strategy to wait until the next month or even longer until the prior month is breached. It's been 5 months of non-stop red bearish declining closes each month as this is the first month to show as currently blue against those prior 5 months.
A beautiful sight to see on the charts.
I just need it to CLOSE on anything above 1470 by the "month end" to make my move.
If it fails to do that, it's telling us something, and the reason I went for safety in ignoring 1280's.
Once aboard, slightly different tactics will then enable me to pick up such a 1280 type of scenario, once the recontinuance of the decades-old uptrend was healthily seen to be back in force, by one and all.
2nd concern is that - if not only does this month close above 1470 but goes steaming past well into £15++ or higher!
That would induce ill-discipline in myself.
I think I can hold out by lashing myself to the ship's mast as we pass the island of the siren calling maidens. Not long to go now, to be free of my odyssey.
Vela it broke your 1470p zone today !!!
Another good day, might even rise through the XD the way the markets are panning out, and still lots of news to come in the short term. At the moment my divi covers the recent drop.
nice to see the reversal in fortune. I am disgusted with those running the London Stock Exchange who want to reduce our top shares to match the price of a' second class postage stamp'. Examine the price of LLOYDS.
The trend is your friend, so grabbing some on the way up is a great strategy.
Getting some on the way down is often difficult, catching the bottom of a downtrend.... but with a stock like GSK I can't believe you weren't tempted to grab some when they were at a near 2 year low sub £13.
Getting them at that price is playing probabilities better imho.
" Will wait for £14.75 plus to....."
-------------------
Ha! Now there's a near-coincidence.
I'm waiting for THE MONTH of November to close ABOVE 1470 - and confirm as near as damn it, that this shorter term downtrend is over.
And that will be my buying signal. AND I will re-enter GSK on that signal.
Mid 1550's would be even better as it confirms two more important areas achieved for me.
- But this month end price - if it achieves it, and or holds above 1470 by this month end, is good enough for re-entering.
So pleased I held back from re-entering sub 1300 as I closed my prior entry upon the realisation I had jumped the gun, so it means a lot to me that I can learn to hold my horses when executing long wait patience stalking - nearly failed the test when I prematurely bought in last month - but quickly closed out.
So don't give a kipper that I let sub 1300 go. It would have been chance and my strategy focuses on probabilities.
Stage 1 = break 1470 by month-end.
Stage 2 = No date for achieving mid 1500's - but that seals the deal for good, and signals full return to the long term uptrend path is full on - in yer face! :)
But first things first. Bring me the head of 1470 - by this month close!
No good the SP achieving it intra-month, then falling and closing below it, no.
Show me brute force and strength - and bring it in!
* sorry, I meant 1280's level
what do you think is going to create the "rinse and repeat" scenario The-Lockie, to take it back down to the 1380's level again?
>Will wait for £14.75 plus to bail. Rinse and repeat.
I think you are selling cheap at that mate
Friday 's £10K top up of stock to trade at £12.96 looks nice now. Will wait for £14.75 plus to bail. Rinse and repeat.
HE HE just love this profit wish i had got more and the div to come :-)
WHO said it might go down to 12.50 ??????? next stop 16.50
GSK is clearly more reliable than the girlfiends !!! 4.7% up on a day when we were all filling up with gloom last week, blue chips aren't meant to go up this quick......
Well thankfully I decided on Sunday that dogs dinner or not, £13 was too cheap so I put in a fill order and went to bed, where I dreamt I was being caressed by an old girlfriend who I had nearly forgotten about. Which is kind of what GSK has been doing to my NPV all week. I might ask the same question about LGEN next week to see if it has the same effect.
Ex dividend date 12th of November 2020
Already have a few thousand shares but surely worth a top up at these prices. Have a spare £15K float in trading account have sold 4 funds this week. 52 week Low.......what can possibly go wrong.
Where will it go in a Trump win or a Biden win ?
Mark, I take you point and perhaps should not have made a blanket
statement, although it is a significant factor imv.
For more context, if you look at a 5 year chart of GSK,
It is often given to these fat moves in either direction
and a good deal of that can be sentiment related.
SAK I take it you have just reacted rather than studying the numbers, which are actually good
Twonko.my point was you could of sold at a profit then bought back at these prices ..wasnt looking for an argument
Not forgetting operating profit
2019 £6,961m
TTM £8,624m
Net profit £m
2019a 4,645
TTMa 6,371
2020E 5,666
2021E 5,798
All numbers are a consensus median of 26 brokers
>Put simply, earnings are falling.
company reported a 3 per cent slide in third-quarter revenues to £8.6bn, while its earnings per share, on an adjusted basis, climbed 1 per cent to 35.6p.
3% drop in R, estimate R for year actuals are
2019 A 33,754
TTM 34,259
2020 E 34,576
2021E 35,698
Yet SP is down -29.8% from 52w high
@billywig. Who's talking about selling? Since I first bought in 2011, I have bought biggish chunks on a further half dozen or more occasions and have never sold any. GSK is my largest single holding, though close to being second to LGEN in all probability. I am very well aware of the divs, which is why I have the shares. My point, if I am making a point at all, which I don't think I am, is that these shares are currently worth around 20% less than they were 9 years ago. Not much that I can think of in this life represents fantastic value if it depreciates by that much . If you think that makes it a bargain, then get your wallet out. If you think it's a dogs dinner, then put your money in the post office. Me? I am undecided, which is partly why I ask the question, though I I intend to do nothing except collect the divs and sincerely hope that I never have to modify that strategy. And I may buy more. Who knows?
Yes, but would ignore that.
Look at Trump's statements on reducing drug costs in 2016/17.
Hot air.
Worries of a Democrat administration lowering US drug prices. Glaxo has a lot of debt and 41% of Group sales are in the US, so it is exposed.
Put simply, earnings are falling.
There are growth areas within the organisation, but no overall growth.
Advair, the last GSK blockbuster, is still contributing around £1 Billion of
revenue annually, that will likely continue to dwindle rapidly.
The last few years for GSK financially, have been about navigating
the Advair patent cliff.
That drug at it's peak contributed about 30% of GSK overall profitability.
Advair was an extraordinary contributer to the P& L.
I'm old enough to remember the giant patent cliff of Zantac,
which transformed GSK fortunes. Long time ago now.
Market corrections are never predictable if they was we would all be rich the worlds in turmoil with the virus and presidential elections next week and on top of that no deal Brexit
Simply out of favour with large investors I guess siddeek- hope Tyler changes if so.